Market Forecast By Origin (Human Primary Cells, Animal Primary Cells), By Type (Hematopoietic Cells, Dermatocytes, Gastrointestinal Cells, Hepatocytes, Lung Cells, Renal Cells, Heart Cells, Musculoskeletal Cells), By End User (Life Science Research Companies, Research Institutes) And Competitive Landscape
Product Code: ETC269148 | Publication Date: Aug 2022 | Updated Date: May 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
South Africa Primary Cells market currently, in 2023, has witnessed an HHI of 2135, Which has increased slightly as compared to the HHI of 1889 in 2017. The market is moving towards moderately competitive. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
South Africa Primary Cells Market report thoroughly covers the by Origin, by Type, and by End User. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
South Africa Primary Cells Market has been witnessing tremendous growth due to increased biotechnological research and development. Primary cells are essential for accurately simulating human physiological conditions, making them valuable in drug discovery and disease modeling. There is a rising trend in the use of primary cells for personalized medicine and significant investments in stem cell research.
According to 6Wresearch, South Africa Primary Cells Market size is expected to grow at a significant CAGR of 7.5% during the forecast period 2024-2030. Several factors are driving the market growth, driven by the rising technological advancements in cell culture and preservation techniques have significantly improved the viability and utility of primary cells for research purposes. Regulatory support from bodies like the South African Health Products Regulatory Authority (SAHPRA) is fostering the development of new medical innovations, further boosting the market. Additionally, the growing focus on personalized healthcare solutions is increasing the demand for primary cells, which are essential for personalized medicine and regenerative therapies, contributing to the South Africa Primary Cells Market growth.
However, the market faces several challenges. The high cost of procuring and maintaining primary cells is a major hurdle. Furthermore, primary cells have a relatively short lifespan and are susceptible to contamination, limiting their practical use. Regulatory and ethical issues, particularly concerning human tissue sourcing, add complexity to the market. Additionally, economic instability and inadequate healthcare infrastructure in some regions of South Africa may impede the widespread adoption and research activities involving primary cells.
South Africa Primary Cells Market is driven by key players such as Lonza Group Ltd., Thermo Fisher Scientific Inc., and Merck KGaA. Lonza Group Ltd. stands out for its broad range of primary cells and cell culture media.
The South African government has launched several initiatives and policies to boost the Primary Cells Market. The National Development Plan 2030 is key, promoting healthcare innovation and research, which supports the use of primary cells in medical advancements. The Revised National Health Research Strategy has increased funding for biotech research, enhancing primary cell applications. The Strategic Health Innovation Partnerships (SHIP) program encourages collaborative research to advance primary cell technologies.
South Africa Primary Cells industry is set for substantial growth due to progress in biotechnology and medical research. Enhanced funding and government backing are expected to boost innovation and the use of primary cell technologies. New trends, such as organ-on-chip models and 3D cell culture, present exciting growth prospects. Nonetheless, overcoming challenges related to cell viability and ethical sourcing is essential. The rise of personalized medicine will likely increase demand, creating significant opportunities for businesses in this field.
According to Nitesh, Research Manager, 6Wresearch, human primary cells are gaining momentum in the market. This rise is due to the growing demand for personalized medicine and the critical role these cells play in regenerative therapies and drug discovery. Human primary cells offer a more accurate reflection of human physiology than animal cells, making them essential for research aimed at developing treatments for human conditions.
Hematopoietic cells are the fastest-growing cell type, crucial for studying and treating blood disorders like leukemia. The increasing occurrence of these diseases, along with advancements in stem cell research and bone marrow transplants, drives the demand for hematopoietic cells in both clinical and research areas.
Life Science Research Companies are leading the market expansion. These companies invest heavily in innovative research and development to create new therapies and diagnostic tools. The focus on personalized healthcare and strong funding for biotechnology advancements make life science research firms key drivers of growth in South Africa's primary cells market.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Primary Cells Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Primary Cells Market Revenues & Volume, 2020 & 2030F |
3.3 South Africa Primary Cells Market - Industry Life Cycle |
3.4 South Africa Primary Cells Market - Porter's Five Forces |
3.5 South Africa Primary Cells Market Revenues & Volume Share, By Origin, 2020 & 2030F |
3.6 South Africa Primary Cells Market Revenues & Volume Share, By Type, 2020 & 2030F |
3.7 South Africa Primary Cells Market Revenues & Volume Share, By End User, 2020 & 2030F |
4 South Africa Primary Cells Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 South Africa Primary Cells Market Trends |
6 South Africa Primary Cells Market, By Types |
6.1 South Africa Primary Cells Market, By Origin |
6.1.1 Overview and Analysis |
6.1.2 South Africa Primary Cells Market Revenues & Volume, By Origin, 2020-2030F |
6.1.3 South Africa Primary Cells Market Revenues & Volume, By Human Primary Cells, 2020-2030F |
6.1.4 South Africa Primary Cells Market Revenues & Volume, By Animal Primary Cells, 2020-2030F |
6.2 South Africa Primary Cells Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 South Africa Primary Cells Market Revenues & Volume, By Hematopoietic Cells, 2020-2030F |
6.2.3 South Africa Primary Cells Market Revenues & Volume, By Dermatocytes, 2020-2030F |
6.2.4 South Africa Primary Cells Market Revenues & Volume, By Gastrointestinal Cells, 2020-2030F |
6.2.5 South Africa Primary Cells Market Revenues & Volume, By Hepatocytes, 2020-2030F |
6.2.6 South Africa Primary Cells Market Revenues & Volume, By Lung Cells, 2020-2030F |
6.2.7 South Africa Primary Cells Market Revenues & Volume, By Renal Cells, 2020-2030F |
6.2.8 South Africa Primary Cells Market Revenues & Volume, By Musculoskeletal Cells, 2020-2030F |
6.2.9 South Africa Primary Cells Market Revenues & Volume, By Musculoskeletal Cells, 2020-2030F |
6.3 South Africa Primary Cells Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Africa Primary Cells Market Revenues & Volume, By Life Science Research Companies, 2020-2030F |
6.3.3 South Africa Primary Cells Market Revenues & Volume, By Research Institutes, 2020-2030F |
7 South Africa Primary Cells Market Import-Export Trade Statistics |
7.1 South Africa Primary Cells Market Export to Major Countries |
7.2 South Africa Primary Cells Market Imports from Major Countries |
8 South Africa Primary Cells Market Key Performance Indicators |
9 South Africa Primary Cells Market - Opportunity Assessment |
9.1 South Africa Primary Cells Market Opportunity Assessment, By Origin, 2020 & 2030F |
9.2 South Africa Primary Cells Market Opportunity Assessment, By Type, 2020 & 2030F |
9.3 South Africa Primary Cells Market Opportunity Assessment, By End User, 2020 & 2030F |
10 South Africa Primary Cells Market - Competitive Landscape |
10.1 South Africa Primary Cells Market Revenue Share, By Companies, 2023 |
10.2 South Africa Primary Cells Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |